Indian derma firm Vyome raises $8m to progress pipeline
This article was originally published in Scrip
Executive Summary
The Indian dermatology firm, Vyome Biosciences, has raised $8m from a clutch of investors led by the private equity firm Sabre Partners as it seeks to advance some of its novel products towards filings and commercialization.